LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
---|---|---|---|---|---|---|---|---|---|---|
MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 24.81 | 84.90 | 1138 | 1769 | 0.6431 | 0.8083 | MN20160318_Q02 | F12 |
MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 26.51 | 84.90 | 803 | 1923 | 0.4175 | 0.6473 | MN20160318_Q02 | C11 |
MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 26.51 | 84.90 | 1054 | 1923 | 0.5481 | 0.7499 | MN20160318_Q02 | C11 |
MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 26.51 | 84.90 | 145 | 1923 | 0.0754 | 0.1263 | MN20160318_Q02 | F12 |
MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 26.51 | 84.90 | 1156 | 1923 | 0.6011 | 0.7862 | MN20160318_Q02 | F12 |
MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 28.21 | 84.90 | 919 | 2091 | 0.4394 | 0.6741 | MN20160318_Q02 | C11 |
MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 28.21 | 84.90 | 1174 | 2091 | 0.5613 | 0.7651 | MN20160318_Q02 | C11 |
MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 28.21 | 84.90 | 212 | 2091 | 0.1014 | 0.2189 | MN20160318_Q02 | F12 |
MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 28.21 | 84.90 | 1169 | 2091 | 0.5589 | 0.7635 | MN20160318_Q02 | F12 |
MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 29.92 | 84.90 | 946 | 2237 | 0.4228 | 0.6665 | MN20160318_Q02 | C11 |
MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 29.92 | 84.90 | 1157 | 2237 | 0.5171 | 0.7392 | MN20160318_Q02 | C11 |
MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 29.92 | 84.90 | 305 | 2237 | 0.1363 | 0.3112 | MN20160318_Q02 | F12 |
MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 29.92 | 84.90 | 1258 | 2237 | 0.5622 | 0.7703 | MN20160318_Q02 | F12 |
MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 31.62 | 84.90 | 978 | 2449 | 0.3992 | 0.6551 | MN20160318_Q02 | C11 |
MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 31.62 | 84.90 | 1143 | 2449 | 0.4666 | 0.7092 | MN20160318_Q02 | C11 |
MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 31.62 | 84.90 | 369 | 2449 | 0.1506 | 0.3538 | MN20160318_Q02 | F12 |
MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 31.62 | 84.90 | 1235 | 2449 | 0.5041 | 0.7366 | MN20160318_Q02 | F12 |
MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 33.32 | 84.90 | 1030 | 2722 | 0.3783 | 0.6469 | MN20160318_Q02 | C11 |
MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 33.32 | 84.90 | 1178 | 2722 | 0.4327 | 0.6917 | MN20160318_Q02 | C11 |
MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 33.32 | 84.90 | 410 | 2722 | 0.1506 | 0.3699 | MN20160318_Q02 | F12 |
MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 33.32 | 84.90 | 1324 | 2722 | 0.4863 | 0.7316 | MN20160318_Q02 | F12 |
MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 35.03 | 84.90 | 1114 | 2991 | 0.3724 | 0.6503 | MN20160318_Q02 | C11 |
MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 35.03 | 84.90 | 1244 | 2991 | 0.4159 | 0.6861 | MN20160318_Q02 | C11 |
MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 35.03 | 84.90 | 552 | 2991 | 0.1845 | 0.4395 | MN20160318_Q02 | F12 |
MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 35.03 | 84.90 | 1371 | 2991 | 0.4583 | 0.7183 | MN20160318_Q02 | F12 |